Macelignan Improves Functional Recovery After Spinal Cord Injury by Augmenting Autophagy via the AKT ‐ mTOR ‐ TFEB Signaling Pathway
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Yuxuan Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Autophagy, Recovery of Function. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Spinal cord injury (SCI) presents considerable therapeutic challenges due to its complex pathophysiology, and effective treatments are currently lacking. Macelignan (Mace) has shown therapeutic effects in some neurological disorders, but its potential to enhance functional recovery in SCI and the underlying mechanisms are not well understood. This research endeavors to explore the therapeutic value of Mace in SCI and its underlying mechanism of action. A mouse model of SCI was established, and the mice were randomly divided into 13 groups: Sham, Sham + Mace, SCI, SCI + 25 mg/kg Mace, SCI + Mace, SCI + 75 mg/kg Mace, SCI + 100 mg/kg Mace, SCI + 3MA, SCI + Mace/3MA, SCI + Mace/Scramble shRNA, SCI + Mace/TFEB shRNA, SCI + SC79, and SCI + Mace/SC79. Histological examinations were conducted using hematoxylin and eosin (HE), Masson's trichrome, and Nissl staining techniques. Functional recovery post‐injury was evaluated through footprint analysis and the Basso Mouse Scale (BMS). The levels of proteins associated with pyroptosis and autophagy were quantified using qPCR, protein immunoblotting, and immunofluorescence (IF). Network pharmacology techniques were applied to elucidate the signaling pathways modulated by Mace. Mace facilitated functional recovery following SCI by augmenting autophagy and diminishing pyroptosis, with these effects being partially counteracted by 3‐Methyladenine (3MA). It was noted that Mace induced autophagy via inhibition of the AKT‐mTOR signaling pathway, leading to an increase in TFEB expression. As an autophagy activator, Mace induces TFEB‐mediated autophagy and inhibits pyroptosis, which supports functional recovery post‐SCI, indicating its potential clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang, China.
- The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China.
- Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Zhejiang, China.
ORCID-Profile: Xiangyang Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Y., Yang, S., Su, S., Huang, Y., Chen, Y., Liang, H., Miao, J., Wu, Z., Li, X., Xiao, J., & Wang, X. (2025). Macelignan Improves Functional Recovery After Spinal Cord Injury by Augmenting Autophagy via the AKT ‐ mTOR ‐ TFEB Signaling Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8473
Vancouver
Zhu Y, Yang S, Su S, Huang Y, Chen Y, Liang H, et al. Macelignan Improves Functional Recovery After Spinal Cord Injury by Augmenting Autophagy via the AKT ‐ mTOR ‐ TFEB Signaling Pathway. Phytotherapy Research. 2025. doi:10.1002/ptr.8473
BibTeX
@article{Zhu2025,
author = {Zhu, Yuxuan and Yang, Shu and Su, Shenkai and Huang, Yeheng and Chen, Yuli and Liang, Haibo and Miao, Jiansen and Wu, Zhouwei and Li, Xiang and Xiao, Jian and Wang, Xiangyang},
title = {Macelignan Improves Functional Recovery After Spinal Cord Injury by Augmenting Autophagy via the AKT ‐ mTOR ‐ TFEB Signaling Pathway},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8473}
}
EUVIMED